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After engraftment neural stem cells (green) integrated into the organotypic culture and 
formed gap-junctional couplings (here visualized by stainings against connexin 43; white) 
to the injured and nestin (red) positive host cells. Cell nuclei are marked with DAPI 
(blue). As described in this thesis communication via gap junctions underlies early 
functional and beneficial interactions between grafted neural stem cells and the host. 
 
 
All previously published papers were reproduced with permission from the publisher. 
 
Published by Karolinska Institutet. Printed by Larserics Digital Print AB. 
 
© Linda Maria Jäderstad, 2012. 
ISBN 978-91-7457-577-4  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
  To Johan 
 
  
  
ABSTRACT 
Neurodegenerative diseases such as Parkinson's disease, Huntington's disease and 
amyotrophic lateral sclerosis and acute neurological disorders such as brain ischemia 
and traumatic injury yearly affect millions of people. Neural stem cell (NSC) grafting is 
an emerging strategy to treat and potentially cure these conditions for which today no 
effective remedies exist. The restoration of function might occur both by replacement 
of lost neural cell populations and by rescue of host cells at risk. In this thesis we have 
investigated the early interactions between grafted NSCs and the injured brain and 
characterized potential mechanisms that underlie the functional improvements seen 
after NSCs grafting. For these aims, we employed an organotypic culture (OC) system 
to model injured neural host tissue and grafted both murine and human NSCs to this 
model. First, we recognized that the OC was a suitable model system to study the early 
interactions between NSCs and the host. After NSC grafting we observed a reduced 
host cell damage using metrics like astrogliosis, apoptosis and necrosis. The grafted 
NSCs also integrated functionally and participated in host calcium signaling networks. 
Employing a combination of immunohistochemistry, RNA interference, pharmaco-
logical blockers, calcium imaging and dye coupling assays we identified gap-junctional 
graft-host couplings as the mechanism that conveyed both the beneficial impact on the 
host and the early functional interactions. We recognized that gap junction expression 
in the grafted NSCs and the injured host cells were highly dynamic processes. The 
investigations of the graft and host gap junction expression indicated a temporal 
window of opportunity for successful NSC engraftment. Finally, we noticed that graft-
host gap-junctional couplings could be increased by treating the human embryonic stem 
cells with a Rho-associated kinase inhibitor. This was paralleled by an increased 
beneficial impact on the damaged host cells. The main conclusion in this thesis is that 
that gap-junctional coupling appears to be one of the first steps by which graft and host 
cells establish functional and beneficial interactions. This precedes the formation of 
more complex communication like chemical synapses. The direct cell-to-cell contact 
allows reciprocal exchange of a multitude of different health promoting substances and 
neutralization of pathological processes by diffusion of harmful substances. Increased 
knowledge of the exact molecular mechanisms involved in the interplay between the 
graft and host, and also how to direct them, can ultimately benefit the potential future 
use of NSCs grafts for the treatment of neurodegenerative disorders. 
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1 INTRODUCTION 
The initial part of the thesis will briefly summarize the current state of the field and 
some of the most important obstacles that remain before neural stem cell 
transplantations can be routinely used in the clinic. The emphasis will be on the topics 
specifically addressed in the included studies (I-IV). 
 
1.1 STEM CELLS 
1.1.1 Definition 
A stem cell is defined by its capacity for self-renewal and the ability to generate more 
differentiated cells (Potten et al. 1990). The regenerative capacity originates from the 
innate capability for symmetric cell division resulting in two identical copies of itself, 
i.e. two “clonogenic” stem cells. The stem cell can also undergo asymmetric cell 
division, which will result in one identical daughter cell and one with more restricted 
potential for differentiation. 
 
1.1.2 Lineage 
Embryonic stem cells (ESC) are derived from the inner cell mass of preimplantation 
embryos (Martin 1981). Similar to the inner cell mass, the in vitro cultured ESCs show 
a pluripotency to form cells of all three germ layers, i.e. endo- meso- and ectoderm. 
Tissue-specific (“adult”) stem cells are found in tissues of the developed organism, like 
bone marrow (Till et al. 1963), intestine (Cheng et al. 1974), skin (Cotsarelis et al. 
1990), lung (Kajstura et al. 2011) and brain (Messier et al. 1958; Altman et al. 1965). 
Such stem cells can differentiate into specialized cell types of the tissue from which 
they came. While the origin of ESCs is known, the origin of adult stem cells is less 
known. One hypothesis is that they escape linage restriction in the early embryo and 
later on colonize their special niches. An alternative and perhaps more widely accepted 
hypothesis is that adult stem cells are derived after the somatic linage specification by 
the dedifferentiation of fate determined cells (Kriegstein et al. 2009). 
 
1.2 NEURAL STEM CELLS 
1.2.1 Neural stem cells during development 
The formation of the central nervous system (CNS) begins with the process of 
neurulation, where the neural plate folds to become the neural tube which fluid-filled 
center later will give rise to the ventricular system and spinal canal. The neural tube is 
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made up by primary progenitors called neuroepithelial (NE) cells. NE cells are radially 
organized and highly polarized cells that touch both the ventricular and basal side of the 
neural tube. During early embryonic development the NE cells undergo symmetric, 
proliferative divisions in order to increase the pool of progenitors (McConnell 1995; 
Rakic 1995). The symmetrical cell division occurs at the ventricular surface, which 
creates a proliferative ventricular zone (VZ). During interphase the NE cells pull their 
nuclei towards the pial surface by a process called interkinetic nuclear migration. In 
later developmental stages the NE cells switch to asymmetrical cell division that 
generates a daughter stem cell and a more fate restricted neural progenitor. At the onset 
of the neurogenesis the NE cells give rise to a distinct cell type, the radial glial cells 
(Kriegstein et al. 2009), that successively during development replace the NE cells. 
Like the NE cells, the radial glial cells remain in contact with the ventricular and the 
pial surface but in contrast they are more fate restricted and generate progenitors for 
either astrocytes, oligodendrocytes or neurons (Malatesta et al. 2000; Noctor et al. 
2001; Noctor et al. 2004). The intermediate progenitor cells originating from the 
asymmetrical division of the radial glial cells typically undergo subsequent symmetric 
divisions to generate terminally differentiated cells. The newly born postmitotic cells in 
the ventricular zone migrate radially along the radial glial processes and consequently, 
most of the cells in the brain are derived from the radial glial cells. The accumulation of 
progenitor cell derivatives that migrates out from the VZ transforms the 
neuroepithelium into a tissue with numerous cell layers (Haubensak et al. 2004; Noctor 
et al. 2004; Merkle et al. 2006). In mammals, radial glial cells exist during the cortical 
development. At the end of this developmental period, the radial glial cells lose their 
ventricular attachment and migrate toward the cortical plate where they finally 
differentiate into astrocytes (Noctor et al. 2008). 
 
1.2.2 Neural stem cells in the adult brain 
There are two major sites for neurogenesis in the adult mammalian brain, the 
subventricular zone (SVZ) (Doetsch et al. 1999) and the dentate gyrus subgranular zone 
(SGZ) of the hippocampus (Gage 2000). The neurogenic cells which reside in these 
areas are considered to be remnants of the embryonic radial glial cells (Merkle et al. 
2004).  
The SVZ contains neural stem cells (NSCs) that line the lateral walls of the lateral 
ventricles. These SVZ cells generate neuroblasts which migrate long distances in chains 
to their final destination, the olfactory bulb, where they differentiate into interneurons 
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(Lois et al. 1994; Belluzzi et al. 2003; Curtis et al. 2007). The hypothesized functional 
role for the newborn neurons in the olfactory bulb is to contribute to odor memory and 
olfactory discrimination (Rochefort et al. 2002). The primary precursor of new 
hippocampal neurons is located in the subgranular zone that lies at the interface of the 
granule cell layer and the hilus. When born, the precursors migrate a relatively short 
distance into the granule cell layer where they differentiate into hippocampal granule 
cells. This adult neurogenesis in the hippocampus has been linked to learning, memory 
and mood regulation (Altman 1969; Gould et al. 1992; Winocur et al. 2006). Why 
neurogenesis in certain confined areas persists into adulthood is not fully understood. In 
the physiologically intact brain, one theory suggests that plasticity is needed in systems 
important for survival, like the ability to detect signs of danger such as smoke or 
contaminated food and to remember these inputs in order to avoid them in the future. In 
the diseased brain, adult neurogenesis is hypothesized to generate a constant source of 
new neurons that will help the brain to self-repair. Currently, evidence for adult 
neurogenesis in other brain regions, including the neocortex (Altman 1963), striatum 
(Dayer et al. 2005), amygdala (Bernier et al. 2002) and substantia nigra (Zhao et al. 
2003) exist, but it is not conclusively demonstrated and awaits further investigation 
(Gould 2007).  
 
1.3 BRAIN INJURY 
1.3.1 Acute injury 
Acute brain injury typically affects entire sections of the brain parenchyma including 
all the consisting neural cells, with a near complete loss of the supporting architecture 
and circuitry often as well as a deterioration of the local blood circulation. The acute 
insult is associated with excitotoxicity, a pathological process which results in the death 
of neurons by, most importantly, excessive glutamate release and sustained elevations 
of intracellular calcium levels (Olney 1969). Glutamate is the most common 
neurotransmitter in the brain but in situations of massive neuronal death, the 
concentration of glutamate reach pathological levels and it becomes toxic due to the 
excessive and prolonged activation of its receptor (Lucas et al. 1957). This leads to the 
influx of calcium to the intracellular compartment and subsequently the activation of 
calcium-dependent catabolic enzymes which will damage different cell structures such 
as components of the cytoskeleton, the membrane and the DNA (Manev et al. 1989). 
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1.3.1.1 Ischemic stroke 
Prolonged interruption of the blood supply leads to deprivation of oxygen and nutrients 
to energy demanding neurons. The affected neurons become dysfunctional within a few 
seconds and show signs of structural damage after just two minutes (Murphy et al. 
2008) due to inability to maintain a normal ion gradient which results in an imbalance 
in the water and ion homeostasis. This ultimately leads to cell damage or death through 
multiple processes like excitotoxicity, acidotoxicity, oxidative stress and inflammation. 
The pathological processes affect not only neurons, but also other non-neuronal cells 
which causes a focal degeneration of the brain parenchyma. The processes have their 
own distinct time frames, some occurring within minutes, others within hours and days 
which ultimately leads to the impairment of sensation, movement or cognitive 
functions executed by the affected area (Doyle et al. 2008). 
 
1.3.2 Chronic injury 
Neurodegenerative disorders are characterized by the slow progressive death of 
neurons, which ultimately leads to a decline of functions performed by the diseased 
region. The degeneration can be focal, with the selective death of a specific neuronal 
population such as in Parkinson's disease (PD) and Huntington's disease (HD), or 
multifocal with a widespread loss of many different neurons as in Alzheimer's disease 
(AD). The pathophysiology is often viewed as cellular dysfunction due to pathological 
protein assembly or aggregate formation (Bruijn et al. 1998; Orr et al. 2000; Walker et 
al. 2000; Sherman et al. 2001; Ross et al. 2004), oxidative stress (Simonian et al. 1996; 
Wiedau-Pazos et al. 1996; Jenner 2003), mitochondrial dysfunction (Boillee et al. 2006; 
Lin et al. 2006; Turner et al. 2007), ion dyshomeostasis (Roy et al. 1998) or 
excitotoxicity (Doble 1999; Hardingham et al. 2010). The initial insult will 
successively lead to the activation of the immune system that will detect and destroy 
diseased neurons (Block et al. 2007; Tansey et al. 2007). The inflammatory response 
contributes to the clinical manifestations, and participates in the development and 
progression of the disease (Wyss-Coray et al. 2002; Block et al. 2005; Mrak et al. 2005; 
Lindvall et al. 2010).  
 
1.3.2.1 Parkinson's disease  
Parkinson's disease is an untreatable and progressive disease that yearly affects over 4 
million of people worldwide (Dorsey et al. 2007). It is the second most common cause 
of neurodegeneration after Alzheimer's disease (Hirtz et al. 2007) and the clinical 
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features involves resting tremor, muscle rigidity, bradykinesia and postural instability 
(Jankovic 2008). The characteristic motor symptoms observed in patients with PD are 
due to the selective death of dopaminergic neuron in the substantia nigra pars compacta 
and the decreased dopaminergic innervation of the striatum which results in deficits in 
dopaminergic neurotransmission. The PD affected dopaminergic neurons exhibit 
cytoplasmic inclusions called Lewy bodies that are rich in α-synuclein (Chu et al. 2007; 
Uversky 2007), a protein needed for normal synaptic function but in affected neurons 
are misfolded and hypothesized to cause neuronal stress and death. The most important 
risk factor is age, but there exists a genetic predisposition for acquiring the disease. The 
exact etiology is however unknown. There is currently no cure for PD. The primary 
goal of existing treatment is threefold; delay the progression of the disease, achieve 
symptomatic relief and to cause as few adverse effects as possible (Barone 2010). 
 
1.3.2.2 Huntington's disease  
Huntington's disease is an autosomal dominant inherited disease, which originally was 
called Huntington’s chorea (the Greek word for dance) due to its display of motor 
dysfunction like involuntary movements, bradykinesia, dystonia and rigidity. In 
addition to motor disturbances, HD also causes cognitive impairment, psychiatric 
disorders and slowing of intellectual processes (Gil et al. 2008). The disease is caused 
by a mutation in the HD gene which encodes for huntingtin, a protein which cellular 
functions is not fully understood but essential for normal brain development (Young 
2003; Walker 2007).  
The mutant protein exhibit a neurotoxic effect through toxic gain of function, i.e. 
protein misfolding and aggregation resulting in disturbed normal cell homeostasis and a 
pathogenic cascade that subsequently leads to cell destruction (Tobin et al. 2000). The 
pathological process shows a striatal selectively and in the advanced stages of HD, a 
nearly complete loss of striatal medium spiny neurons is observed (Halliday et al. 
1998). The treatment for HD is symptomatic, aiming to reduce and postpone motor 
dysfunction, cognitive decline and psychiatric disturbances. 
 
1.3.2.3 Amyotrophic Lateral Sclerosis 
Amyotrophic lateral sclerosis (ALS) is characterized by the selective death of upper 
and lower motor neurons (Cleveland et al. 2001; Rothstein 2009). The most prominent 
clinical ALS characteristics are muscle weakness and wasting leading to death, 
typically due to respiratory failure within three years after diagnosis (Eisen 2009). The 
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etiology is unknown, but likely there are a multitude of different genetic and 
environmental factors that in combination cause the disease. To date, few genetic or 
environmental risks have been discovered (Gordon 2011). A minority of all ALS cases 
are due to mutations in the superoxide dismutase 1 (SOD1) enzyme which normally 
catalyses the conversion of reactive oxygen species (ROS) to less harmful substances. 
The mutant SOD1 protein has a susceptibility to form aggregates (Shaw et al. 2007) 
due to protein misfolding (Nordlund et al. 2008) which leads to increased cellular 
vulnerability and subsequently death. Treatment is aiming at postpone ventilator-
dependence, symptomatic relief and palliative care. 
 
1.4 BRAIN REPAIR 
1.4.1 Recruitment of endogenous neural stem cells 
It is estimated that between 0.03% and 0.3% of the neuronal populations in rodent 
hippocampus and SVZ function as stem cells (Peterson 2002). Considering the 
extraordinary potential for a single stem cell, this low percentage might still provide a 
considerable regenerative capacity. Although the presence of active germinal zones in 
the adult brain is well established, it is generally considered that the regeneration 
provided by these areas is ineffective and insufficient during brain injury. The limited 
ability for self-repair is hypothesized to depend on the restricted locations of NSCs and 
limitations imposed by the surrounding microenvironment (Martino et al. 2006). NSCs 
are however found in situ in response to various insults such as ischemia (Jin et al. 
2001; Arvidsson et al. 2002; Tonchev et al. 2003), trauma (Gould et al. 1997), epilepsy 
(Zhao et al. 2008) and neurodegeneration (Fallon et al. 2000). A number of studies 
indicated that neurogenesis is part of a self-repair process in several disease states like 
HD (Curtis et al. 2003), AD (Jin et al. 2004) and in a rodent model of ALS (Chi et al. 
2006). Interestingly, neurogenesis in PD is in contrast decreased (Hoglinger et al. 
2004). 
 
1.4.2 Neural stem cell engraftment 
Neural stem cell grafting holds great promise as a potential cure for several diseases 
that today are incurable. As discussed by (Lindvall et al. 2010) several major obstacles 
remains before stem cell grafting can be routinely used. The different conditions stem 
cells have the potential to treat are heterogeneous in their nature and exhibit great 
variability in severity. Patients suffering from PD have normal life expectancy and 
there exist drugs which are safe and effective. In contrast, ALS is a rapidly progressing 
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disease that always leads to death within a few years after symptomatic onset. While 
the severity of a disease like ALS might justify the potential risks of NSC 
transplantation, like tumor formation (Brustle et al. 1997; Deacon et al. 1998; Wernig et 
al. 2004; Gruen et al. 2006), dyskinesia (Freed et al. 2001; Politis et al. 2010), allodynia 
(Hofstetter et al. 2005) and seizures, these side effects are unacceptable for a PD 
patient.  
Clinical stem cell transplantation in neurodegenerative diseases states is still 
experimental, but preliminary trials have showed some functional benefit. The first 
applications of stem cell grafting to patients were attempted in PD, where two patients 
received embryonic substantia nigra tissue grafted to the striatum. However, the 
procedure provided temporary and modest functional recovery (Lindvall et al. 1989). 
This led to changes in used protocol were the age of donors was reduced, more fetal 
tissue was grafted and measurements were undertaken to reduce brain trauma in 
connection with the transplantation procedure. These measurements resulted in a 
significant functional recovery in the third and fourth patient to be grafted (Lindvall et 
al. 1990). Today, graft-induced dyskinesias have suspended the clinical trials.  
The second neurodegenerative disease to be addressed was HD. Limited data 
suggest symptomatic amelioration and some retrieval of motor and cognitive functions 
which are stabilized at least for six years after transplantation with embryonic striatal 
tissue (Bachoud-Levi et al. 2000a; Bachoud-Levi et al. 2000b). The first clinical trial 
with transplantation of NSCs to patients with stroke has recently been initiated 
(Lindvall et al. 2011). Previous transplantation of pre-differentiated NSCs derivates to 
patients with stroke have resulted in an improved cognitive and motor function 
(Kondziolka et al. 2000; Stilley et al. 2004). Application of NSC transplantations to 
ALS patients also is in its infancy. A phase I trial is currently ongoing to test whether 
the injection to the spinal cord is safe (Aboody et al. 2011). 
The mechanisms underlying the beneficial graft and host interplay and how this 
reciprocal interaction can lead to restored function needs to be better understood before 
safe transition to the clinic. This is one of the most important goals of stem cell research 
today. 
 
1.4.3 Repair mechanisms 
1.4.3.1 Replacement of lost cells 
The functional improvements following NSC engraftment have traditionally been 
attributed to replacement of missing neurons. The success of NSC engraftment is likely 
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depending on the complexity of the affected circuitry. When specific neuronal 
populations is affected like in PD and ALS, successful engraftment would require both 
selective replacement of lost neurons and the reestablishment of the original 
connections with proximal and distant host afferent and efferent fibers. It is known that 
when NSCs are grafted to a brain region were a certain neuronal subgroup is 
degenerated they respond by shifting their pattern of differentiation towards the missing 
cell type (Rosario et al. 1997; Snyder et al. 1997; Flax et al. 1998) but a complete 
reconstitution of neuronal connectivity is difficult to achieve. More extensive 
requirements have to be met when the cell replacement is aimed to treat focal lesions 
that cause loss of several different cell types, such as in ischemic stroke. In this case, 
transplanted cells should be able to populate a post-infarct cavity and to regenerate all 
the lost neural cell types in appropriate relative numbers, and to reestablish long 
distance connections with the host circuitry and to restore a functional vascular 
compartment. 
 
1.4.3.2 Rescue of damaged host cells 
There is a growing body of evidence indicating that NSCs can provide direct support to 
host cells at risk (Ourednik et al. 2002; Li et al. 2006a; Chintawar et al. 2009). These 
processes may even be of equal importance as host cell replacement. The host cell 
rescue and reactivation of function after NSC grafting may in part be attributed to the 
NSCs capacity to secrete diffusible factors needed for neuronal health and in part due to 
their ability to form direct cell-to-cell contacts to dysfunctional host cells and through 
the intercellular contacts mediate exchange of molecules that promote survival and 
neutralize pathological processes. Some of the more extensively described diffusible 
factors delivered by NSCs to damaged neighboring host cells are growth factors like 
brain derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor 
(GDNF) and nerve growth factor (NGF) (Lu et al. 2003; Pluchino et al. 2003; Lee et al. 
2007; Madhavan et al. 2008) which through receptor mediated actions contribute to cell 
homeostasis and survival.  
Formation of direct cell-to-cell gap-junctional channels between graft and host cells 
allows direct exchange of several different molecules like adenosine, adenosine 
triphosphate (ATP), ions, amino acids, glutathione, genetic material and polypeptides 
which together with a diffusion and buffering of harmful substances which both enable 
grafted NSCs to restore and retain normal host cell homeostasis (Li et al. 2006a; 
Rouach et al. 2008; Chintawar et al. 2009; Goodenough et al. 2009). 
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2 AIMS  
The main objective of this thesis was to investigate early mechanisms underlying cell 
level interactions between graft and host cells following NSC engraftment to CNS 
tissue.  
 
The more specific objectives of the thesis were 
 To establish and optimize an ex vivo organotypic slice culture model suitable to 
study cell level graft and host interactions.  
 To characterize the morphological integration of implanted NSCs. 
 To estimate host cell effects induced by the grafted NSCs. 
  To evaluate the influence of growth factors on host cell survival and 
differentiation of grafted stem cells. 
 To investigate if communication via gap junctions underlies the early functional 
and beneficial interactions between grafted NSCs and the host.  
 To study the dynamic changes in gap junction expression following engraftment 
of NSCs and based on these findings evaluate potentially important factors for 
the optimal timing of the NSC engraftment.  
 To test if pre-treatment with a Rho-associated kinase inhibitor can enhance gap-
junctional communication between grafted stem cells and the host and if this 
pharmacologically enhanced communication is associated with increased 
beneficial effects on the host. 
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3 METHODS 
This chapter contains a brief summary of the most important methods used. A complete 
listing and descriptions that are more detailed are to be found in the articles included in 
this thesis. 
 
3.1 STEM CELLS 
3.1.1 Murine neural stem cells 
Two clones from the C17.2 cell line were employed to model the behavior of NSCs 
(Snyder et al. 1992). The, by now, well characterized C17.2 cell line was originally 
derived from postnatal day (P) 4 mouse cerebellum and retrovirally transfected with the 
myc gene to preserve multipotency, self renewal and an undifferentiated state in vivo 
(Parker et al. 2005). It is further engineered to express the β-galactosidase encoding 
lacZ gene (Snyder et al. 1992) and green fluorescent protein (GFP) for recognition of 
grafted cells (Ourednik et al. 2002; Lu et al. 2003). To study the effects of grafting 
NSCs in various stages of differentiation, a C17.2 subclone that routinely yields a high 
proportion of young neurons was utilized. This subclone has been genetically modified 
to secrete large amounts of neurotrophin (NT)-3 which operate upon both NSCs and 
host cells in an autocrine/ paracrine fashion (Lu et al. 2003). Throughout the thesis the 
NSC clone overexpressing NT-3 will be referred to as ‘NSC-NT-3’ and the clone 
expressing only GFP as ‘NSC-GFP’. 
In addition to the C17.2 cell line, another NSC preparation was used in the 
spinocerebellar ataxia type 1 (SCA1) mouse model employed in Study II (described in 
section 3.8.2). These NSCs were derived from the SVZ of four to eight week old 
FVB/N mice and the cells were engineered to express GFP to enable recognition (Gritti 
et al. 1999). The mouse neural stem cells (mNSCs) were cultured as previously 
described (Gritti et al. 1999; Lu et al. 2003) and detailed in Study II. 
 
3.1.2 Human neural stem cells 
Three different preparations of human neural stem cells (hNSCs) were used, none of 
which were genetically modified or carried any transgenes. In Study I and II HFB2050 
(Flax et al. 1998), an hNSC line isolated from the telencephalic ventricular germinal 
zone of a 13-week-old fetal cadaver, was used. In Study II, HFB11ws6 and HCX11ws6 
(Carpenter 1999; Castelo-Branco et al. 2003; Piao et al. 2006; Akesson et al. 2007) 
both derived from cerebral cortex and subcortical regions of an 11-week-old fetal 
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cadaver were used for characterization of their calcium homeostasis, dye coupling and 
connexin expression. The different preparations of hNSCs were maintained as 
previously described (Brewer et al. 1993; Flax et al. 1998) and detailed in Study I and 
II. 
 
3.1.3 Human embryonic stem cells 
In Study IV the H181 cell line (Hovatta et al. 2003), derived from discarded blastocysts 
after in vitro fertilizations, were used as graft material to study if less mature embryonic 
stem cells were associated with the same beneficial impact on the host as more 
differentiated neural stem cells. The human embryonic stem cells (hESCs) were not 
genetically manipulated and had a normal karyotype. The hESCs were maintained and 
cultured as previously described (Imreh et al. 2004) and detailed in Study IV. 
 
3.1.3.1 Pre-treating hESC with Rho-associated kinase inhibitor 
In Study IV, the Rho-associated kinase inhibitor (ROCKi) Y-27632 was used in order to 
enhance the connexin expression in hESCs. This was done by exposing the hESCs to 
10 µM Y-27632 in cell culture medium 8 hours prior to engraftment to the organotypic 
culture (Anderson et al. 2002; Watanabe et al. 2007). 
 
3.2 ORGANOTYPIC CULTURES  
To study graft and host interactions, roller-drum organotypic cultures (OCs) were 
employed (Gahwiler 1981). The roller-drum technique for culturing nervous tissue was 
introduced 65 years ago (Hogue 1947), and has since then mostly been used for 
anatomical (Gahwiler et al. 1997), pathological (Kaal et al. 2000; Testa et al. 2005), 
developmental (Becq et al. 2005; Liu et al. 2005) and pharmacological studies (Corse et 
al. 1999; Ray et al. 2000; Sundstrom et al. 2005). Lately, the membrane interface 
method (Stoppini et al. 1991) where the brain slices rest on a porous membrane at the 
interface between medium and a humidified atmosphere, has grown more popular. The 
membrane interface method preserves the three-dimensional structure and the tissue 
architecture in a way that the roller-drum setup is unable to achieve. Instead, the roller-
drum technique facilitates flattening of the brain slice due to the constant rotation. 
During time in culture the tissue transforms from a thick opaque slice to a highly 
accessible thin layer of cells. Although the original structure is changed, the neuronal 
connectivity, cell type composition and cell-to-cell interactions are preserved (Gahwiler 
et al. 1997). Due to the thinning of the slice to a near monolayer of cells, the roller-
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drum setup provides pristine optical conditions and ideal circumstances to study cell 
level graft and host interactions, which is unachievable using any other model. The 
major drawbacks of the OC system are the absence of the immunological response and 
a functional vascular system (Lossi et al. 2009).  
Organotypic striatal cultures were prepared as previously described (Gahwiler 
1981). Briefly, newborn Sprague-Dawley rats were killed by decapitation at P 2 to 6 
and the striatum was dissected out and stored in Gey's Balanced Salt Solution (GBSS). 
The striatal tissue was cut in 250 µm thick coronal slices using a McIlwain tissue 
chopper and transferred to fresh GBSS to allow tissue debris and potentially toxic 
substances, such as excitatory amino acids, to diffuse away. The tissue slices were 
carefully separated and subsequently moved to tissue water. Tissue slices were then 
placed on 12 x 24 mm glass cover slips and embedded in reconstituted chicken plasma 
coagulated by bovine thrombin. Cover slips containing the organotypic culture were 
finally placed in Falcon tubes with 1.1 ml medium (for medium composition, see 
section 3.2.1). The cultures were grown at 37°C in 5% CO2 in a roller-drum device 
exposing the cells to gaseous and liquid phase every 30 seconds. The OCs were 
evaluated after 7, 14, 21 and 28 days in vitro (DIV). In Study IV, all cultures were 
evaluated at 21 DIV. 
 
3.2.1 Maintenance of organotypic cultures 
Grafted and non-grafted cultures were maintained in organotypic culture medium 
consisting of 55% Dulbecco's Modified Eagle Medium with 25mM HEPES, Sodium 
Pyruvate and 1000 mg/L glucose, 32.5% Hanks Balanced Salt, 10% Fetal Bovine 
Serum, 1.5% D-(+)Glucose 20% solution, 1% HEPES and 1% Penicillin/ 
Streptomycin/ Fucidin. Additionally, to test whether external cues could direct 
differentiation and promote a neuronal fate in grafted mNSCs, a subset of grafted 
cultures were grown in Neurobasal culture medium supplemented with B27 (Brewer et 
al. 1993). This serum-free medium was originally developed to enhance survival of 
hippocampal neurons but has gained wide recognition for its differentiation-inductive 
properties in a number of CNS tissues such as the striatum, cerebellum and substantia 
nigra (Brewer 1995). Neurobasal/B27 medium was prepared by mixing Neurobasal™ 
with 2% B27 supplement, 1% L-glutamine (200 mM) and 1% Penicillin/ Streptomycin/ 
Fucidin. Throughout the thesis, this culture medium is abbreviated ‘NB/B27 medium’ 
and the organotypic culture medium is abbreviated ‘OC medium’. The culture medium 
was changed every third day. 
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3.3 ENGRAFTMENT OF STEM CELLS 
In Study I-III, NSCs were grafted to the OCs after 48-hour exposure to 1 µM of the 
alkylating agent Mitomycin C (MMC). The mNSCs were grafted as a cell suspension 
with a concentration of 300-500 cells/µL. A total of 10 µL cell suspension was 
dispersed within 1 mm from the striatal tissue, resulting in 3-5 x 103 NSCs per OC and 
a 1:40-50 NSC:OC cell ratio.  
In Study IV, colonies of hESCs where carefully removed from the underlying layer 
of feeder cells with a sterile needle after treatment with Dispase (10 mg/ml). Four to 
five colonies, approximately 2 x 104 cells, per OC were added in close vicinity to the 
striatal tissue that resulted in a 1:200 hESCs:OC cell ratio. 
To allow adherence of the grafted cells, cover slips were left in a horizontal position 
at 37°C in 5% CO2 for 30-45 minutes before returning them to the Falcon tubes. For 
descriptions of the grafting procedures used for the in vivo models, see Study II. 
 
3.4 RECOGNITION OF GRAFTED STEM CELLS 
Grafted mNSCs were identified by their GFP expression, whereas an antibody against 
Heat chock protein (Hsp) 27 was used for detection of human NSCs and ESCs. The 
Hsp27 staining was visualized using fluorescent secondary antibodies labeled with 
Alexa 488 or 546. Immunohistochemical protocols are described below. In Study II, a 
subset of HFB2050 cells were pre-labeled with the membrane bound fluorescent dye 
1,1'-dioctadecyl-3,3,3'3'-tetramethylindocarbocyanine perchlorate (DiI) (Honig et al. 
1986). 
 
3.5 IMMUNOHISTOCHEMISTRY  
Standard immunohistochemical protocols were applied. In summary, grafted and non-
grafted cultures were fixed with 4% paraformaldehyde (PFA) for 5-10 minutes and 
then rinsed twice with phosphate buffered saline (PBS). The cultures were incubated 
with the primary antibodies in a humidity chamber over night at 4°C. After rinsing the 
primary labeled OCs three times with PBS, they were incubated with fluorescent-
tagged secondary antibodies in the same humidity chamber at room temperature for one 
hour. After rinsing three times with PBS the labeled OCs were finally counterstained 
with DAPI nuclear stain. 
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3.5.1 Proliferation, gliosis and apoptosis 
To assess the effects of stem cell grafting on host cell viability three different antibodies 
were used, glial fibrillary acidic protein (GFAP), cleaved caspase-3 (CC-3) and Ki67. 
The preparation of OCs in itself includes a traumatic perturbation involving axotomy 
and excitotoxicity with subsequent reactive astrogliosis. The astrocytic marker GFAP 
was used to estimate the progression of the reactive astrogliosis and the evolution of the 
injury afflicted to the OC during establishment. CC-3 immunostaining was performed 
as a supplement to GFAP labeling as a metric for cell viability. Caspase-3 is a zymogen 
that is activated upon cleavage, both by the extrinsic and intrinsic apoptotic pathway. 
The activation of caspase-3 ultimately leads to apoptosis. In Study IV the proliferation 
marker Ki67, which labels cells during late G1, S, G2 and M phases of the cell cycle, 
was used to assess host and graft cell well-being. 
 
3.5.1.1 Other techniques for evaluation of host cell damage 
In order to assess cell viability on single cell level, propidium iodine (PI) staining was 
preformed. For PI staining, unfixed cultures were quickly rinsed in PBS and incubated 
in 20 μg/ mL PI for 10 minutes at room temperature, followed by fixation with 4% PFA 
in PBS for 5 minutes. PI binds to DNA of necrotic or late apoptotic cells and when it is 
bound to nucleic acid, its red fluorescence is enhanced 20-30 fold. 
Evaluation of the overall OC viability was performed by judgment of transparency, 
color and boarder morphology. Cultures which after 7 DIV were pale, had an opaque 
appearance and distinct borders were considered to be non-viable and were discarded. 
To validate the accuracy of this method, a double-blind trial with trypan blue was 
preformed and accuracy was found to be 100%. 
 
3.5.2 Neural markers 
To identify neurons three different antibodies were used; Tuj1, Map2ab and 
synaptotagmin. Tuj1 labels class III β-tubulin, which is present in immature neurons. 
Map2ab labels slightly more mature neurons, which expression peaks at the time for 
axonal growth, but before synaptic activity. Synaptotagmin labeling is indicative of 
mature neurons capable of chemical synaptic transmission. For information about the 
neuronal markers used in the in vivo models, see Study II. 
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3.5.3 Connexin markers 
To evaluate the presence of connexins (Cx), the substrate for gap junction formation, 
we used two different antibodies directed towards Cx26 and Cx43. Gap junctions are 
formed by the consolidation of two connexons, each consisting of six connexin 
subunits, on adjacent cells. Gap junctions containing Cx26 are present in neural 
precursor cells (Leung et al. 2002; Montoro et al. 2004) while gap junctions containing 
Cx43 are apparent in ESCs (Worsdorfer et al. 2008), neuronal progenitor cells (Rouach 
et al. 2002; Khan et al. 2007), radial glial cells (Dermietzel et al. 1989) and mature 
astrocytes (Rozental et al. 2000). 
 
3.6 FLOW CYTOMETRY 
Flow cytometry was used in Study I to determine the GFP expression in mNSCs and in 
Study III to evaluate the temporal changes in connexin expression in graft and host 
cells. Flow cytometry allows rapid quantification of large number of cells. For 
preparation of single cells, expanded mNSCs were trypsinized, fixed with 4% PFA, 
centrifuged and resuspended in PBS. Grafted OCs were trypsinized for 10 minutes and 
then gently removed from the cover slip with a cell scraper. The tissue was then 
carefully triturated with a pipette and 10% fetal calf serum was added to inactivate the 
trypsin. For fixation, 4% PFA was added to give a final concentration of 2% for 15 
minutes. The suspension was centrifuged and resuspended in PBS. For 
immunocytochemical labeling, primary antibodies were added for one hour and 
thereafter secondary antibodies for 30 minutes. After each step, the suspension was 
centrifuged and resuspended in PBS.  
The cell fluorescence signals were determined using a FACSort flow cytometer 
(Becton Dickinson, San Jose, CA). A primary gate based on physical parameters 
(forward and side light scatter) was set to separate cells from debris. Negative and 
positive controls were used to set the detection range. In order to decide GFP 
expression in mNSC a native C17.2 clone with no GFP expression was used as a 
negative control. As a positive control, mNSCs with a well known and by microscope 
verified strong GFP expression in all cells (the NSC-NT-3 clone) was used. For the red 
spectrum, the background levels in both NSCs and OC cells were estimated by treating 
the cells with the secondary antibody and by omitting the primary antibody. The upper 
detection range was adjusted using fluorescent beads with colors exactly corresponding 
to the used secondary labels. Using this approach, cells within the first decade in the 
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fluorescence plots were considered as negative and cells within the second to third 
decades were considered as positive for the investigated parameters. 
 
3.7 FUNCTIONAL CHARACTERIZATION 
3.7.1 Calcium imaging 
Calcium imaging was performed in Study II to investigate how grafted NSCs 
participate in and affect host calcium based network activity. To estimate intracellular 
Ca2+ levels fluorescent Ca2+ indicators were used. These indicators change their light 
absorption and/or emission characteristics upon Ca2+ binding. We used the calcium 
indicator Fluo-4 to evaluate overall activity and host cell-to-cell communication in non-
grafted cultures and the indicator Fura-2 for ratiometric imaging. For a detailed 
description of the methodology, see Study II. 
 
3.7.2 Dye transfer 
3.7.2.1 Scrape loading 
In addition to calcium imaging, scrape loading experiments were performed to evaluate 
the functionality of gap-junctional couplings between the NSCs, hESC and between 
grafted NSC derivates and host cells. Expanded hESCs in Study IV, or grafted OCs in 
Study II and III were immersed in a dye solution containing 0.5 mg/ml Lucifer Yellow 
(LY) and 0.5 mg/ml Rhodamin-Dextran (RD) diluted in PBS for one minute. A tear 
was made through the hESC colony/grafted OC using a surgical blade. The preparation 
was then incubated for 30 to 60 minutes to allow dye spread. Due to its high molecular 
weight (10.000 Da) RD is too large to be transferred between neighboring cells via gap 
junctions and thus serves as a control dye whereas the low molecular weight dye LY 
(457.2 Da) easily passes through gap-junctional couplings (Stewart 1981) (see also Fig. 
2a, Study III). The amount of dye spreading was expressed as the ratio between LY and 
RD filled cells. In Study IV the amount of dye spreading was estimated based on the 
dye spread area instead of the number of cells. 
 
3.7.2.2 Dye transfer from pre-loaded neural stem cells 
To study gap-junctional coupling between grafted NSC progeny and host cells in a non-
invasive fashion, dye transfer from DiI labeled and calcein pre-loaded NSCs was 
investigated in Study II using a previously described protocol (Goldberg et al. 1995). 
Similarly to LY, calcein is able to pass through gap junctions due to its small size (995 
Da), while the dye DiI is bound to the membrane of the grafted cell. Hence, if 
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functional gap junctions are established, calcein is transferred from the DiI positive 
grafted NSCs to neighboring DiI negative OC cells. The amount of dye spreading was 
expressed as the ratio of calcein and DiI positive cells. For further details, see Study II. 
 
3.7.2.3 Dye transfer following microinjection 
To further test the presence and functionality of gap-junctional couplings between graft 
and host cells, dye transfer after micropipette dye injection directly into the grafted 
NSCs was studied in subset of grafted cultures in Study II. Grafted NSCs were injected 
with 0.1% LY and RD using glass micropipettes. After patching the grafted cells, dye-
spread was photographed repeatedly over a 30 minute time period. Dye-spread was 
thereafter also evaluated in fixed slices using a confocal laser scanning microscope and 
digital three-dimensional reconstruction.  
 
3.7.3 Whole cell patch clamp electrophysiology 
To determine neuronal membrane properties in Study II, basic whole-cell patch-clamp 
recordings were performed in expanded NSCs, NSC progeny and OC cells. The resting 
membrane potential (Vm), membrane resistance (Rm) and ability to generate action 
potentials were determined in examined cells. The protocols are detailed in Study II. 
 
3.7.4 Gap junction inhibition 
To examine whether the gap-junctional couplings could be blocked and to estimate the 
associated effects on the graft-host interplay we utilized both pharmacological blockers 
and RNA interference (RNAi). The pharmacological agents 18-α-glycyrrheetinic acid 
(18-α-GA) and carbenoxolone (CBX) was used to block gap junction function in Study 
II and Study II, III and IV, respectively. However, these substances are non specific and 
to avoid off target effects the more specific RNAi method targeting Cx 26 and Cx43 
was used (Spray et al. 2006). For a detailed description, see Study II. 
 
3.7.5 Western blot 
To detect presence of Cx26 and Cx43 in mNSCs and in hNSCs, routine 
immunoblotting was performed in Study II as previously described (Salomonsson et al. 
2002). Immunoblotting was also made in purpose to estimate the level of Cx43 protein 
suppression in RNAi treated cells. For details, see Study II. 
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3.8 IN VIVO MODELS 
In order to investigate if the beneficial effects seen after mNSC engraftment to OCs 
were also present in vivo, three different in vivo models were investigated in Study II. 
This was done in cooperation with Jianxue Li and Richard L. Sidman at Harvard 
Medical School (the nervous mouse model), Satyan Chintawar and Massimo Pandolfo 
at Université Libre de Bruxelles (the spinocerebellar ataxia type 1 mouse model) and 
Yang D. Teng at Harvard Medical School (the contused cervical spinal cord rat model). 
 
3.8.1 Nervous (nr) mouse model 
The nervous (nr) mutation originally occurred in the BALB/cGr mouse strain (Li et al. 
2006b). In this mutant mouse model, a majority of the Purkinje neurons (PNs) die by 
the forth to fifth postnatal weeks due to excessive tissue plasminogen activator activity 
(tPA). By P 21 all affected animals will exhibit characteristic like hyperactivity and 
ataxia. For details see (Li et al. 2006b). 
 
3.8.2 Spinocerebellar ataxia type 1 mouse model 
The spinocerebellar ataxia type 1 (SCA1) mouse model (Burright et al. 1995) 
recapitulate many pathological and behavioral characteristics of the human disease 
spinocerebellar ataxia type 1. SCA1 is a hereditary neurodegenerative disorders caused 
by the expansion of a CAG trinucleotide repeats which is translated into a 
polyglutamine tract in the ataxin-1 protein (Orr et al. 2007). The ataxin-1 is localized in 
cerebellar PNs and through a toxic gain of function the faulty protein destroys the 
affected cells (Bowman et al. 2007). The SCA1 mouse model develops a progressive 
motor disorder starting at about five weeks of age. For details see (Chintawar et al. 
2009).  
 
3.8.3 Contused cervical spinal cord rat model 
Spinal cord injury was induced in Sprague-Dawley rats by creating a four millimeter 
long longitudinal cut along the midline of the spinal cord at cervical level 4-5. For 
details see (Teng et al. 2002).  
 
3.9 ETHICAL PERMISSIONS 
All animal experiments were performed in accordance with European Community 
guidelines and approved by the regional animal research ethics committees at 
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Karolinska Institutet, Harvard Medical School and Université Libre de Bruxelles 
respectively. 
 
3.10 STATISTICAL METHODS 
Statistical differences between groups with equal variance were determined by 
ANOVA and post hoc Bonferroni tests. Variance was determined by the Brown-
Forsythe test. Categorical responses were compared with Fisher’s Exact Test. 
Differences were considered to be statistical significant at P<0.05*, P<0.01** and 
P<0.001***. Data are presented as means ± SEM. 
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4 RESULTS AND DISCUSSON 
This chapter summarizes the most important findings in the thesis with brief reflections 
and a final general discussion. 
 
4.1 ORGANOTYPIC CULTURES AS A MODELL SYSTEM 
In Study I we characterized the organotypic culture and evaluated if it was a suitable 
model system to study graft and host interactions. The culture system was analyzed 
weekly during 28 DIV. During this time period it gradually thinned from initially 250 
µm to a thin layer of cells. The thinning of the OCs was mainly due to cell migration 
and cell death which was facilitated by the gravitational forces generated by the 
constant rotation in the roller drum device [Fig. 1a, b]. 
 The original tissue architecture was altered during the time in culture but most of the 
neuronal connectivity was retained which was demonstrated by preserved 
synaptotagmin stainings. The plasma and thrombin clot that initially covered the OCs 
dissolved during the first days in vitro but still caused some background fluorescence 
when the cultures were immunostained at 7 DIV.  
At the time of OC establishment (0 DIV) nestin expression in cryosectioned striatal 
tissue was estimated to 10 ± 1% and GFAP expression to 4 ± 1%. This expression 
increased to 56 ± 4% respectively 63 ± 3% after 7 DIV, but returned to lover levels 
after 28 DIV, 26 ± 2% and 24 ± 3% respectively. The dynamics in nestin and GFAP 
expression can be viewed as metrics of cellular stress and correlates to the degree of 
injury inflicted upon the OCs during establishment (Frisen et al. 1995; Pekny et al. 
2005). The feature of nestin and GFAP manifestations as response to injury, the 
reproducibility of the OC system, the unmatched optical conditions combined with the 
tissue thinning during time in vitro, provided an optimal platform to study cell level 
graft and host interactions. 
 
4.2 STEM CELL ENGRAFTMENT 
4.2.1 Neural stem cells before engraftment 
In Study I-III we investigated the survival, proliferation and differentiation of the C17.2 
clone. Thawing and expanding stem cells generated large quantities of undifferentiated 
mNSCs. The undifferentiated state of the mNSCs was reflected by their nestin 
expression. The majority of both the NSC-GFP and NSC-NT-3 cells expressed the 
stem and progenitor cell marker nestin. The NSC-NT-3 clone was already at the time  
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Figure 1. Grafted neural  stem  cells  survived and  integrated  throughout  the organotypic 
culture. The striatal tissue slices used to establish the organotypic culture gradually thinned‐
down and spread out during the time in culture. At the first day in culture, the striatal tissue 
slice  had  an  opaque  appearance  and  well‐defined  boarder  [a].  Subsequently,  during 
progressive time  in culture,  it transformed to a thin  layer of cells at 28 DIV [b]. Stem cells 
grafted within 1 mm from the organotypic culture migrated towards the slice and integrated 
into the host tissue [c]. The highlighted area in [c] is displayed at increased magnification in 
[d]. The grafted mNSCs were recognized by GFP fluorescence (green). DAPI nuclear stain  is 
blue and GFAP is red. Scale bars: 200 μm in [a], 100 μm in [b, c] and 20 μm in [d].           
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for engraftment more prone to differentiate towards a neuronal linage and had started to 
express the early neuronal marker Tuj1 (9 ± 2%). NSC-NT-3 also expressed small 
amounts of GFAP. Besides being an astrocytic marker GFAP has also proven to be 
expressed by many postnatal and adult-derived NSCs (Alvarez-Buylla et al. 2001).  
All examined cells retained their β-galactosidase expression revealed by the X-gal 
stainings. NSCs also had a strong GFP expression at the time for engraftment, which 
remained during the entire studied culturing period. 
The MMC treatment did not affect the morphology of the NSCs and effectively 
halted the NSCs in the cell cycle. In a subset of experiments, we grafted non-MMC 
treated mNSCs to the OCs. This was associated with overgrowth and subsequently 
caused detachment of the striatal tissue and NSCs from the cover slip. 
 
4.2.2 Neural stem cells after engraftment 
Grafted mNSC gradually migrated towards and integrated into the striatal tissue [Fig. 
1c, d]. After 28 DIV the mNSC were fully integrated into the striatal tissue and 
morphologically formed a part of the host parenchyma. The ratio of surviving mNSCs 
compared to the original NSC number grafted was 0.8 ± 0.02 after 28 DIV, which 
corresponded to a mNSC:OC cell ratio of 1:10.  
The NSC-GFP clone reduced its nestin and GFAP expression, while the Tuj1 and 
Map2ab remained constant during time in vitro. The neural maturation could in part be 
induced by culturing in NB/B27 medium, which favored the Map2ab expression, but 
had little effect on the Tuj1 expression. After 28 DIV in OC medium the Map2ab 
expression was 6 ± 1% and the Tuj1 expression 44 ± 3%. When culturing in NB/B27 
medium the NSC-GFP cells expressed 67 ± 2% Map2ab and 41 ± 3% Tuj1. Why the 
Map2ab expression but not the Tuj1 expression was enhanced by the serum-free 
medium may be explained by altered transcription of mNSC genes induced by the mix 
of external cues. 
The NSC-NT-3 clone reduced its nestin and GFAP expression during the time in 
vitro. After 28 DIV 0.2 ± 0.1% and 0.6 ± 0.4% of the NSC-NT-3 cells were reactive for 
nestin and GFAP while 70 ± 2% and 19 ± 4% expressed Tuj1 and Map2ab. The 
Map2ab expression could further be induced by culturing in the NB/B27 medium, 
which after 28 DIV resulted in a Map2ab expression of 68 ± 3%.  
Neither culturing in serum-free NB/B27 medium nor endogenous NT-3 over-
expression could however promote a complete differentiation of the grafted cells 
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towards fully mature neurons. During the studied 28 day time period none of the 
grafted cells displayed positive synaptotagmin stainings. 
We also concluded that the strong neuronal differentiation of the NSC-NT-3 clone, 
reflected in Tuj1 and Map2ab expression, made it especially suitable for studies of 
interactions between grafted young neurons and host cells. 
  
4.3 ENGRAFTMENT PROVED BENEFICIAL FOR THE HOST 
In Study I and II we evaluated the influence of the grafted NSCs on the host cells after 
implanting mNSCs to striatal organotypic cultures. For this we employed nestin and 
GFAP immunostainings to estimate cellular stress, PI and CC-3 stainings to quantify 
the amount of necrotic and apoptotic cells and the overall survival of the OC as a 
general measurement of the outcome. Host cell stress, depicted by the nestin and GFAP 
expression, was reduced by 25-30% during the first and second week in culture when 
the OCs were grafted with the NSC-GFP clone. A similar impact on the host cells was 
observed when OCs were grafted with the NSC-NT-3 clone, with a 28% reduction in 
nestin reactivity and a 43% decline in GFAP expression after 14 DIV. We also noticed 
that host cell necrosis, estimated by PI staining at 7 DIV, was reduced by 86% when 
OCs were grafted with the NSC-GFP clone and by 71% when grafted with the NSC-
NT-3 cells. In addition, the CC-3 expression was reduced by 78% and 64%, 
respectively. The same parameters were investigated in Study IV at 21 DIV after hESC 
engraftment. A similar beneficial impact was witnessed using hESCs. In this case, 
GFAP was reduced by one fourth while CC-3 expression was decreased by two thirds. 
The OC cell necrosis was however unaffected. 
 The overall survival increased by 43% after engraftment with the NSC-GFP clone. 
The timing of the NSCs implantation turned out to be of importance. Grafting mNSCs 
to the OCs 0-24 hours after establishment resulted in an increased overall survival. 
However, grafting mNSCs 48-72 hours after establishment was not associated with an 
increased overall survival and grafting cells 96-144 hours after establishment, 
unexpectedly, had a negative effect on OC survival. This indicate that grafted mNSC, 
which entered to the acutely damaged tissue were able to aid cell survival but when 
grafted to a fully matured injury they were unable to assisting continued existence of 
host cells. Engraftment with the more neuronally predestined clone, NSC-NT-3, was 
not associated with any improvement in overall survival. Since engraftment of both the 
NSC-GFP and NSC-NT-3 clone was associated with comparable reductions in host cell 
gliosis, necrosis and apoptosis we concluded that the beneficial effects observed in this 
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model were not dependent of growth factor overexpression. NT-3 is known to be a 
neuroprotective agent (Connor et al. 1998) and exerts its effect by TrkC receptor 
activation. These receptors are present in the striatum (Escandon et al. 1994; Lamballe 
et al. 1994; Jung et al. 1996) so the lack of a more pronounced beneficial effect on 
striatal cells must be explained by another mechanism than altered NT-3/TrkC 
activation. A possible explanation might be coupled to naturally secreted growth factors 
like BDNF and GDNF, which are produced by the native mNSCs. Likely due to the 
increased NSC differentiation induced by NT-3 overexpression, GDNF and BDNF 
secretion is decreased in NSC-NT-3 cells (Lu et al. 2003). Since both GDNF and 
BDNF are potent neuroprotective factors (Deierborg et al. 2008) the limited effects 
exhibited by the NSC-NT-3 clone might instead be explained by the decreased GDNF/ 
BDNF secretion.  
 
4.4 GRAFT AND HOST COMMUNICATION 
In Study II the electrophysiological properties of NSC derived cells and host cells were 
determined. Non-grafted mNSCs displayed limited sodium/ potassium (Na+/K+) 
channel activity and had a less pronounced resting membrane potential (Vm) and high 
membrane resistance (Rm). After engraftment to OCs the mNSCs showed significant 
developmental differences in both Vm and Rm. After 28 DIV 66% of the mNSC 
displayed active membrane properties and ability to fire single action potentials, 
indicative of differentiation towards a neuronal phenotype. The number of Na+/K+ 
channel was however insufficient to generate repetitive action potentials characteristic 
of fully mature neurons. This indicated that the four weeks of culturing in the 
organotypic culture system, was not enough to allow complete maturation of the 
grafted mNSCs. Previous studies have shown that neuronal maturation is a time 
consuming process, where synaptic connectivity takes up to 60 days to form (Toni et al. 
2007). Despite the absence of neurons capable of repetitive firing, extensive functional 
communication between graft and host cells was present in the form of synchronous 
calcium (Ca2+) fluctuations.  
Spontaneous fluctuations were commonly observed in both grafted and non-grafted 
OCs. Both ATP and glutamate could provoke such fluctuations. In half of all the 
examined grafted OCs, synchronous Ca2+ fluctuations between grafted mNSCs and 
striatal host cells were noticed. The temporal overlapping Ca2+ fluctuations indicated 
that mNSC were able to participate in Ca2+ mediated host networks and become a 
functional part in host Ca2+ mediated circuitry. Because calcium transients is known to 
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be spread through the P2 purinergic receptors (P2R) upon ATP activation and since 
application of ATP evoked transient and sustained Ca2+ elevations in the majority of 
both mNSCs and OC cells, the P2R antagonist suramin was applied in order to 
determine the mechanism underlying the synchronous graft host Ca2+ activity. Suramin 
did however not affect the overlapping Ca2+ events, suggesting that the interplay 
between mNSCs and OC cells was not dependent on ATP-P2R interactions. It is known 
that during normal CNS development oscillatory patterns of electrical activity, rather 
than mature chemical synapses, interpret the biological blueprint and orchestras the 
formation of the cortex (Weissman et al. 2004). The presence of calcium wave 
signaling between grafted mNSCs and OC cells seemed to recapitulate events from 
embryonic development. We knew that gap junctions are widely expressed during 
embryonic development and provide a route for cell-to-cell contact and communication 
that can mediate the spread of Ca2+ waves across cell populations (Elias et al. 2007; 
Elias et al. 2008). Therefore, we hypothesized that formation of gap junctions underlies 
the coupled Ca2+ fluctuations and the early functional integration of grafted mNSCs. 
 
4.5 GAP JUNCTION FORMATION BETWEEN GRAFT AND HOST CELLS 
Gap junctions are formed by the consolidation of two connexons on adjacent cells. 
Each connexon consists of six connexin subunits. These intracellular bridges connect 
the cytoplasm of neighboring cells and allow the exchange of small molecules less than 
1000 Da through passive diffusion (Goodenough et al. 2003). However, larger 
molecules can evidently pass through if they have the correct three-dimensional 
structure (Neijssen et al. 2005; Cieniewicz et al. 2010).  
Since Cx26 and Cx43 are important during neural development (Cina et al. 2007; 
Elias et al. 2008; Goodenough et al. 2009) and increased Cx43 expression is a hallmark 
of injured neural tissue (Rouach et al. 2002) we choose to focus on these and 
investigated their expression in both host and graft cells. Both connexin subtypes were 
commonly seen in OC cells. Cx43 often co-localized with nestin and GFAP, while 
Cx26 co-localized with Tuj1 expressing host cells. Before engraftment, 49 ± 14% of 
the mNSCs expressed Cx43 and 9 ± 2% expressed Cx26. After grafting, the mNSCs 
started to form functional gap junctions with host cells already two hours post 
engraftment. After 3 DIV there was a marked increased in connexin-expression, 92 ± 
1% of the mNSC expressed Cx43 and 24 ± 1% expressed Cx26.  
During the 28 DIV we observed that the Cx43 expression declined whereas the 
Cx26 expression in mNSCs increased. Since the mNSCs initially had a nestin/GFAP 
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positive phenotype which successively changed into a Tuj1 positive phenotype during 
the 28 DIV, it seemed that the changes in connexin expression paralleled the maturation 
of the mNSCs. We concluded that Cx43 expression was associated with immature 
mNSCs and non-neuronal cells, while the Cx 26 expression was associated with 
neuronally differentiated mNSCs.  
To investigate whether the presence of connexins and functional gap junctions in 
mNSCs, was a unique finding or if it could have a wider applicability, we studied the 
same variables in hNSC grafts. Similar results were obtained. The hNSCs also 
expressed Cx43 and formed gap junctions upon initial contact with OC cells. As for 
mNSCs the hNSCs were also able to functionally integrate into host Ca2+ mediated 
networks. 
To evaluate the functionality of the gap-junctional couplings, standard dye loading 
experiments were performed. Scrape loading, dye transfer from pre-loaded NSCs and 
dye transfer following microinjection (as described in section 3.7.2) showed extensive 
spreading of the gap-junctional permeable dyes LY and calcein, indicative of functional 
gap-junctional couplings between both grafted human and murine NSCs and host 
striatal cells. 
 
4.6 BLOCKING GAP-JUNCTIONAL COMMUNICATION 
The role of gap-junctional couplings in the graft-host interplay was verified using a 
combination of inhibition strategies. Transfer of LY and calcein from grafted NSCs to 
neighboring OC cells as well as coupled graft-host Ca2+ transients was effectively 
suppressed by the pharmacological gap junction channel blockers CBX and 18-α-GA. 
In addition, pharmacological inhibition of gap junction function abrogated the 
beneficial impact grafted mNSCs and hNSCs exerted on host cells. Following CBX 
treatment of grafted cultures, the gliotic response in OC cells was comparable with that 
of the non-grafted cultures. To more specifically investigate the impact of gap-
junctional communication on host cell well-being and to avoid off target effects caused 
by the pharmacological inhibitors, we complemented the gap junction blocking studies 
by suppressing Cx26 and Cx43 in the mNSCs using RNAi techniques. Blocking the 
Cx43 formation by 30-70% abrogated the beneficial effects of NSC grafting in a dose 
dependent manner, i.e. the antigliotic actions were more prominent when engrafting 
mNSCs with 70% of the Cx43 expression retained compared to when grafting mNSCs 
with only 30% of the original Cx43 expression. Blocking Cx26 alone had little effect 
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on host cell gliosis, suggesting that the therapeutic action exhibited by the mNSC was 
mainly mediated by Cx43. 
 
4.7 HOST CELL RESCUE IN VIVO  
In order to investigate whether the intracellular cross-talk held translational relevance 
(i.e. was relevant in other model systems) we examined the interactions between 
grafted mNSCs and host cells in vivo. We employed two mouse models where 
transplanted cells had proven to rescue imperiled host neurons.  
In the SCA1 mouse model, the mutated protein ataxin-1 causes selective death of 
PNs. The mutant mice exhibit at 24 weeks of age a significant loss of PNs which results 
in severe ataxia and behavioral changes. When transplanting NSCs, originated from the 
subventricular zone of adult SCA1 mice a promoted survival of PNs, behavioral 
amelioration, improved cerebellar morphology and a restored PN excitability was 
observed, even though no grafted cells adopted the morphological and 
immunohistochemical characteristics of PNs. Rather, this near-normal histological, 
anatomical and behavioral findings was due to preserved host PNs (Chintawar et al. 
2009). The mNSCs mediated host cell rescue was witnessed only when there was a 
direct contact between transplanted cells and host PNs and immunohistological analysis 
revealed an extensive presence of Cx43 at the interface between rescued PNs and 
transplanted mNSCs. This local connexin reactivity was not detected in sham-
transplanted or wild-type animals. 
In the nr mouse model the same PNs degenerate through another mechanism, but 
are likewise saved by transplanted NSCs. When NSCs are transplanted to the 
premorbid nr mouse the mNSCs can rescue a majority of the PNs from an impending 
death if there is a direct cell-to-cell contact between the transplanted cells and the host 
cells (Li et al. 2006a). Immunohistochemistry showed abundant Cx43 but no, or very 
little, Cx26 expression between rescued PNs and exogenous mNSCs. Wild type and 
non-transplanted nr mice did not express the same abundant immunoreactivity for 
Cx43. To determine if suppression of gap junction formation would abrogate the 
mNSCs mediated rescue, we inhibited Cx43 expression in donor mNSCs with RNAi. 
This strategy yielded surviving PN numbers as poor as in non-transplanted nr mouse. 
Again, the rescuing effect was dependent on the level of RNAi suppression. When 
transplanting mNSC transfected with non-functional RNAi the mNSCs continued to 
promote PN survival.  
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In the contused cervical spinal cord rat model grafted hNSC promote recovery of 
motor and respiratory function. Immunohistological analysis revealed Cx43 between 
graft and host cells. Cx43 expression was not observed in the absence of engraftment. 
In summary, we observed that grafted mNSC reduced OC gliosis, necrosis and 
apoptosis and increased overall survival, integrated functionally in Ca2+ mediated host 
networks and were extensively dye coupled. These features could be hindered either by 
employing pharmacological gap junction blockers or by suppressing connexins by 
RNAi, especially Cx43. Observations from three different in vivo models indicated that 
the findings had a translational relevance. 
 We concluded that gap junction formation appeared to be a crucial early step and set 
the stage for the functional interplay between grafted cells and host cells that ultimately 
lead to a beneficial outcome for the host. 
 
4.8 CONNEXIN EXPRESSION CHANGED AFTER ENGRAFTMENT 
In the second study we noticed that there were clear temporal aspects affecting the 
outcome of mNSC grafting. The time point for the NSC implantation greatly influenced 
the overall survival of the OCs and an early engraftment proved beneficial for the host 
while late engraftment even was associated with a decreased overall survival. Data 
from Study II indicated that gap junctions underlie functional and beneficial interactions 
between the grafted neural stem cells and the host. In Study III we therefore choose to 
investigate the dynamics in connexin expression and gap junction formation in mNSCs 
and OC cells at different time points after engraftment in order to determine if there 
existed an optimal time window for engraftment.  
Estimated by flow cytometry recordings the NSC-GFP and the NSC-NT-3 clone 
expressed high levels of Cx43 (92% and 94%, respectively) and lower levels of Cx26 
(21% and 24%, respectively) before engraftment. After engraftment, the connexin 
expression in mNSCs displayed significant changes. At 7 DIV the immunoreactivity 
for Cx43 in NSC-GFP and NSC-NT-3 was 95 ± 1% and 85 ± 1%, respectively After 28 
DIV the expression had decreased to 47 ± 4% and 28 ± 3%, respectively. As previously 
described, the Cx43 immunoreactivity was typically co-localized with nestin and GFAP 
and decreased during the progressive neuronal differentiation and progression towards 
a Tuj1 positive phenotype. The lower Cx43 expression in the NSC-NT-3 clone could 
hence be explained by its intrinsic predestination towards a neuronal linage (Lu et al. 
2003). The pattern of Cx43 expression could also be altered by exogenous growth 
   29 
factors. Culturing mNSCs in NB/B27 medium reduced the Cx43 expression through its 
neuronal inducing properties (Brewer 1995).  
In the acutely isolated striatal tissue, approximately one fourth of the examined cells 
expressed Cx43. After 7 DIV nearly all of the examined cells expressed Cx43. At later 
stages (14-28 DIV) the OC cell connexin expression returned to lower levels. The Cx26 
expression in grafted mNSCs and host cells did not display consistent temporal and 
growth factor mediated changes comparable to those evident for Cx43. This might 
reflect a different function of Cx26 consistent with our findings in Study II, where we 
conclude that Cx43 played a more prominent role as a health promoting substrate. 
When aligning the Cx43 expression profiles in mNSCs and OC cells, we realized that 
there were a synchronous peak in graft and host Cx43 expression at 7 DIV. The 
overlapping elevations of Cx43 could set the stage for beneficial graft-host interactions 
and thereby potentially create a “window of opportunity” for optimal stem cell grafting. 
Within this time window, there are optimal conditions for host cell rescue by direct 
health promoting interaction with grafted cells is at and subsequently mNSC mediated 
rescue via gap junction channels. 
 
4.9 ENHANCING THE GRAFT AND HOST COMMUNICATION 
In Study IV, we investigated if pharmacological pretreatment of the hESCs could be 
used to increase connexin expression and thereby enhance the beneficial graft and host 
interplay. The Rho-associated kinase inhibitor (ROCKi) Y-27632, Fausidil®, is 
clinically used as a migraine medicine and has been showed to augment gap-junctional 
couplings in retinal epithelial cells (Anderson et al. 2002). It has been applied in clinical 
practice for nearly 20 years (Zhao et al. 2006). We employed ROCKi as a strategy to 
increase connexin expression both pre- and post engraftment. An eight hours exposure 
to ROCKi increased the Cx43 expression in expanded hESCs by 61% (from 40 ± 3% to 
66 ± 3%) and was accompanied by a 250% more extensive dye spread compared to 
non-treated hESCs. The dye spread could be blocked by the pharmacological gap 
junction blocker CBX. When grafting ROCKi treated hESCs, host cell gliosis was 
reduced to 16 ± 1% compared to 33 ± 3% when grafting native hESCs. Surprisingly, 
the host cell necrosis in OCs grafted with ROCKi treated hESCs was higher compared 
to cultures grafted with non-ROCKi treated hESCs. This may be due to off-target 
effects since even relatively selective ROCK inhibitors such as Y-27632 have been 
shown to inhibit other kinases than ROCK (Anderson et al. 2002). Nevertheless, Rho-
associated kinase inhibition presents a promising strategy to increase graft and host 
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interactions. This might be important for the optimization of therapeutic stem cell 
applications. 
4.10 GENERAL DISCUSSION 
The main finding in this thesis is that the formation of gap junctions is a pivotal first 
step where graft and host cells establishes functional communication which ultimately 
leads to increased host well-being. We observed that the formation of gap junctions 
goes through a series of dynamic changes after the NSCs engraftment which can be 
altered by the use of pharmacological agents. 
 Gap junctions are widely expressed during embryonic development and provide a 
mean of cell-to-cell contact and communication and can also act as adhesive molecule 
which aids neuronal migration in the cortex (Elias et al. 2008). The wide distribution 
and conservation of connexins in different neural cells underline their fundamental role 
for cell function and health (Kumar et al. 1996). The importance of gap junctions in 
brain pathology is reflected by observations that aberrations in connexins and gap 
junctions are associated with disorders like stroke (Rouach et al. 2002), AD (Nagy et al. 
1996), PD (Rufer et al. 1996) and HD (Vis et al. 1998). Whether alteration in gap 
junction expression is a cause or a consequence in different brain pathologies is a 
matter of scientific dispute. The relationship between brain pathologies and 
modulations in gap-junctional couplings is highly complex and current data present a 
contradictory picture (Rouach et al. 2002). Alteration in gap junction function can 
ultimately lead either to “bystander death” by the propagation of the injury through gap 
junctions to neighboring cells or alternatively to a “good Samaritan effect” where 
healthy cells rescue dying cells by buffering ions and harmful metabolites or by directly 
supplying beneficial metabolites (Farahani et al. 2005; Leis et al. 2005; Nakase et al. 
2006). The establishment of functional gap junctions between grafted stem cell progeny 
and host cells at risk permits direct delivery of factors that promote survival like ATP, 
ions (De Maio et al. 2002), small interfering ribonucleic acid (siRNA) (Valiunas et al. 
2005), glutathione (Alexander et al. 2003), second messengers (Niessen et al. 2000; 
Bedner et al. 2005) and polypeptides (Neijssen et al. 2005) as well as neutralize 
pathological molecules or processes like ROS and excitotoxicity. Gap junctional 
coupling between graft and host cells might also permit implanted stem cells to directly 
participate and influence host cell calcium basted activity. Calcium fluctuation serve as 
a key regulated of many cellular vital processes [Fig. 2]. We believe that these 
mechanisms in part explain the beneficial effects seen after stem cell grafting to the 
injured CNS. 
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Figure 2. Stem cell interactions with the injured brain. Grafted stem cells interact with the 
host tissue through a multitude of mechanisms. Injured central nervous system (CNS) tissue 
(top  left,  red  cells)  is  typically  characterized  by  ion  dyshomeostasis,  energy  depletion, 
excitotoxicity, altered gene transcription and accumulation of reactive oxygen species (ROS) 
and  other  harmful  metabolites.  Stem  cells  (green  cells)  which  are  grafted  into  this 
environment, can either replace lost cells (top right, lost cells marked by dotted contours) 
or rescue host cells at risk (bottom right, orange cells). This might occur by a combination of 
support  by  secreted  factors  and  direct  beneficial  interactions  via  gap  junctions.  Through 
established graft‐host gap junctions, added stem cells can supply host cells with supporting 
molecules  such  as  adenosine,  ADP,  ATP,  glutathione,  genetic  material  and  second 
messengers  and  simultaneously  “buffer”  harmful  events  such  as  ion  dyshomeostasis  and 
production of ROS and other harmful substances. The direct gap junctional link also enables 
a direct  route  for  calcium‐based  communication, which potentially  could  change  the host 
cells  internal  calcium  fluctuations  toward  a  more  beneficial  pattern.  Calcium  signaling 
patterns  govern  diverse  cellular  processes  such  a  cell  differentiation,  proliferation, 
migration, gene expression, exocytosis and apotosis. 
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5 CONCLUSIONS 
This thesis illustrates that organotypic striatal cultures (OC) provide a suitable model 
system to study graft and host interactions. After engraftment to the OCs the NSCs 
survived, differentiated and gradually became morphologically and functionally 
integrated into the host parenchyma. The NSC differentiation could be directed towards 
a neuronal lineage by serum free culturing conditions and endogenous over expression 
of growth factors.  
Gap-junctional couplings preceded the formation of chemical synapses, and this 
form of communication appears to be one of the first steps whereby grafted cells and 
host cells establish functional and beneficial interactions. The intracellular cross talk 
between coupled graft and host cells was associated with a beneficial impact on the 
damaged host cells, as estimated by metrics like host cell astrogliosis, necrosis, 
apoptosis and overall OC survival. The gap junction expression pattern was highly 
dynamic in both in graft and host cells. The co-incidence of gap junction expression 
peaks in graft and host cells early after engraftment indicated a window of opportunity 
for optimal NSC engraftment. Finally, a pharmacological Rho-associated kinase 
inhibitor could be used to actively increase the gap junctional communication in hESC. 
The effect was paralleled by a more pronounced beneficial impact upon the damaged 
host cells after grafting ROCKi treated stem cells.  
The exact mechanisms underlying graft host gap junctional communication and the 
exact identity of the transferred molecules that mediate the beneficial effects however 
remain to be investigated. This in itself opens the field for a multitude of future studies. 
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